1. World Health Organization. Global tuberculosis report 2016. Geneva: WHO; 2016.
2. •• American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000;161(Suppl 3):S221–47. This is the official statement regarding the management of latent TB issued by the American Thoracic Society (ATS), Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of America (IDSA).
3. Lobue P, Menzies D. Treatment of latent tuberculosis infection: an update. Respirol Carlton Vic. 2010;15(4):603–22.
4. •• World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: WHO; 2015. These are the WHO guidelines for the management of LTBI based on both published evidence and an expert panel.
5. •• Lewinsohn DM, Leonard MK, LoBue PA, Cohn DL, Daley CL, Desmond E, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):111–5. This is the latest update on the clinical guidelines for diagnosis of TB from ATS, CDC and IDSA.